Brentuximab vedotin: unexpectedly good response in CD30- mycosis fungoides.

Brentuximab vedotin: unexpectedly good response in CD30- mycosis fungoides. Br J Dermatol. 2019 Jun;180(6):1300-1301 Authors: Sun J, Wang Y PMID: 31157447 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31157447?dopt=Abstract

Source: The British Journal of Dermatology - May 31, 2019 Category: Dermatology Authors: Sun J, Wang Y Tags: Br J Dermatol Source Type: research

More News: Cutaneous T cell lymphoma | Dermatology | Mycosis Fungoides | Skin | UK Health